BCL2L1 Antikörper
-
- Target Alle BCL2L1 Antikörper anzeigen
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL2L1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- Protein G purified
- Immunogen
- Recombinant Human Bcl-2-like protein 1 protein
- Klon
- 3D1C1
- Isotyp
- IgG1, IgG1 kappa
- Top Product
- Discover our top product BCL2L1 Primärantikörper
-
anti-BCL2-Like 1 (BCL2L1) (AA 1-233) antibody
BCL2L1 Reaktivität: Human WB, ELISA, IF, PLA Wirt: Maus Monoclonal 3E2-2A5 unconjugated
anti-BCL2-Like 1 (BCL2L1) antibodyBCL2L1 Reaktivität: Human WB, IF, IP, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 1-120) antibodyBCL2L1 Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 2-212) antibodyBCL2L1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 2-212) antibodyBCL2L1 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 2-212) antibodyBCL2L1 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal C2 unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 1-233) antibodyBCL2L1 Reaktivität: Human WB, IF, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 1-209) antibodyBCL2L1 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 81-200) antibodyBCL2L1 Reaktivität: Human, Maus, Ratte, Schwein, Schaf WB, ELISA, FACS, IHC (p), ICC, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (pSer62) antibodyBCL2L1 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution:WB:1:500-1:5000,IHC:1:50-1:500,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BCL2L1 (BCL2-Like 1 (BCL2L1))
- Andere Bezeichnung
- BCL2L1 (BCL2L1 Produkte)
- Hintergrund
-
Background: Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.
Aliases: Bcl2-L-1,Apoptosis regulator Bcl-X,BCL2L1,BCL2L, BCLX
- UniProt
- Q07817
- Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
-
